STAT News · Scour

STAT+: Pharmalittle: We’re reading about the FDA pushing OTC meds, its new trial standards, and much more

statnews.com·12w

Does the world need ‘guy-necologists’?

statnews.com·12w

STAT+: Hims to buy Eucalyptus as it looks to expand globally

statnews.com·12w

STAT+: What to expect from Gossamer Bio’s late-stage lung disease study

statnews.com·12w

STAT+: 5 key people to watch at HHS after Trump’s shake-up

statnews.com·12w

Opinion: I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me

statnews.com·12w

Should semen analysis become the Pap smear for men? Some men’s health experts say yes

statnews.com·12w

Opinion: My biggest GLP-1 ethical problem: patients who don’t want to stop

statnews.com·12w

STAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance

statnews.com·12w

STAT+: NIH Director Bhattacharya to lead CDC after O’Neill’s exit

statnews.com·12w

Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines

statnews.com·12w

STAT wins fourth Polk Award for reporting on impact of Trump on health

statnews.com·12w

STAT+: AI Prognosis: Who’s keeping tabs on how health insurers are using AI?

statnews.com·12w

STAT+: Investors cheer Compass’ psilocybin data

statnews.com·12w

STAT+: Pharmalittle: We’re reading about an FDA reversal on a Moderna vaccine, the U.K. life sciences sector, and more

statnews.com·12w

STAT+: The FDA’s Moderna pirouette is one more sign of chaos at the agency

statnews.com·12w

Proposed $7.25B settlement to resolve weedkiller cancer lawsuits

statnews.com·12w

STAT+: FDA reverses course, agrees to review Moderna’s flu vaccine

statnews.com·12w

STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy

statnews.com·12w

Opinion: I was a Moderna exec when the Covid vaccine rolled out. That spirit of possibility is no more

statnews.com·12w

Log in to enable infinite scrolling